Recently, on the basis of these observations, the same authors investigated the potential of this molecule as an agent for imaging and therapy of GRPR-positive mammary carcinoma and reported the ability of [67Ga]NeoBOMB1 to specifically localize in the tumors of mice bearing T-47D breast xenografts [77]. Here, GRPR is linked to breast carcinoma.